EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men

Selina Mäkinen, Sreesha Sree, Tuulia Ala-Nisula, Henric Kultalahti, Peppi Koivunen, Heikki A Koistinen

Diabetologia · 2024-09 · 67 (9) · 1943-1954

DOI: 10.1007/s00125-024-06185-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetologia, online erschienen am 30.05.2024. Verfasst von Selina Mäkinen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Minerva Foundation Institute for Medical Research, Helsinki, Finland. Hauptthemen laut MEDLINE: Muscle Fibers, Skeletal, Glucose, Glycine, Isoquinolines. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Finland, Terveyden Tutkimuksen Toimikunta, Sigrid Juséliuksen Säätiö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/hypothesis Hypoxia-inducible factor prolyl 4-hydroxylase (HIF-P4H) enzymes regulate adaptive cellular responses to low oxygen concentrations. Inhibition of HIF-P4Hs leads to stabilisation of hypoxia-inducible factors (HIFs) and activation of the HIF pathway affecting multiple biological processes to rescue cells from hypoxia. As evidence from animal models suggests that HIF-P4H inhibitors could be used to treat metabolic disorders associated with insulin resistance, we examined whether roxadustat, an HIF-P4H inhibitor approved for the treatment of renal anaemia, would have an effect on glucose metabolism in primary human myotubes.

Methods

Primary skeletal muscle cell cultures, established from biopsies of vastus lateralis muscle from men with normal glucose tolerance (NGT) ( n =5) or type 2 diabetes ( n =8), were treated with roxadustat. Induction of HIF target gene expression was detected with quantitative real-time PCR. Glucose uptake and glycogen synthesis were investigated with radioactive tracers. Glycolysis and mitochondrial respiration rates were measured with a Seahorse analyser.

Results

Exposure to roxadustat stabilised nuclear HIF1α protein expression in human myotubes. Treatment with roxadustat led to induction of HIF target gene mRNAs for GLUT1 (also known as SLC2A1 ), HK2 , MCT4 (also known as SLC16A4 ) and HIF-P4H-2 (also known as PHD2 or EGLN1 ) in myotubes from donors with NGT, with a blunted response in myotubes from donors with type 2 diabetes. mRNAs for LDHA , PDK1 and GBE1 were induced to a similar degree in myotubes from donors with NGT or type 2 diabetes. Exposure of myotubes to roxadustat led to a 1.4-fold increase in glycolytic rate in myotubes from men with NGT ( p =0.0370) and a 1.7-fold increase in myotubes from donors with type 2 diabetes ( p =0.0044), with no difference between the groups ( p =0.1391). Exposure to roxadustat led to a reduction in basal mitochondrial respiration in both groups ( p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscle Fibers, SkeletalGlucoseGlycineIsoquinolinesHumansMaleHypoxia-Inducible Factor-Proline DioxygenasesDiabetes Mellitus, Type 2Cells, CulturedMiddle AgedGlycolysisHypoxia-Inducible Factor 1, alpha SubunitAdult

Stichwörter der Autor:innen

Glucose metabolismHypoxia-inducible factorInsulin resistanceInsulin signallingPrimary human muscle cellsRoxadustat

Substanzen

roxadustatGlucoseGlycineIsoquinolinesHypoxia-Inducible Factor-Proline DioxygenasesHypoxia-Inducible Factor 1, alpha Subunit

Autor:innen und Institutionen

  • Minerva Foundation Institute for Medical Research, Helsinki, Finland.
  • Department of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, Oulu Center for Cell-Matrix Research, University of Oulu, Oulu, Finland.
  • Minerva Foundation Institute for Medical Research, Helsinki, Finland. heikki.koistinen@helsinki.fi.
  • Department of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. heikki.koistinen@helsinki.fi.

Förderung

  • Research Council of Finland
  • Terveyden Tutkimuksen Toimikunta
  • Sigrid Juséliuksen Säätiö
  • Helsinki University Hospital
  • Liv och Hälsa Foundation
  • Suomen Kulttuurirahasto
  • Jalmari ja Rauha Ahokkaan Säätiö
  • Finska Läkaresällskapet

Zitieren

APA

Mäkinen, S., Sree, S., Ala-Nisula, T., Kultalahti, H., Koivunen, P., & Koistinen, H. A. (2024). Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men. Diabetologia, 67(9), 1943-1954. https://doi.org/10.1007/s00125-024-06185-6

Vancouver

Mäkinen S, Sree S, Ala-Nisula T, Kultalahti H, Koivunen P, Koistinen HA. Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men. Diabetologia. 2024;67(9):1943-1954. doi:10.1007/s00125-024-06185-6

BibTeX
@article{Mkinen2024,
  author = {Mäkinen, Selina and Sree, Sreesha and Ala-Nisula, Tuulia and Kultalahti, Henric and Koivunen, Peppi and Koistinen, Heikki A},
  title = {Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men},
  journal = {Diabetologia},
  year = {2024},
  volume = {67},
  number = {9},
  pages = {1943--1954},
  doi = {10.1007/s00125-024-06185-6}
}
Kostenlos starten →